LaserBlood | EIC Pathfinder Project

Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with a survival rate under 10%, largely due to late detection. The LaserBlood project aims to develop a nanoparticle-based blood test for early diagnosis, potentially reducing mortality by up to 80%.

Read More About the Project Click Here to Access CORDIS Website

LaserBlood Consortium

Coordinator

Partners

Subscribe to LaserBlood newsletter